solution peptides retatrutide price glp-3 Reta (GLP-3) 20mg GLP-3 (RT) Triple G 99%+

doi: 10.2147/DMSO.S387116 177 GibbonsCBlundellJTetens HoffSDahlKBauerRBkdalT

Journal of Biological Chemistry

Retatrutide peptide is primarily being studied for the treatment of obesity and metabolic disorders

The same study found that people taking Wegovy were more likely than those in the placebo group to lose 5, 10, 15, or 20% of their starting weight

5-8 Clinical trials confirmed blood sugar benefits and showed that these medications also reduce risk of cardiovascular events in diabetics, including heart attack and stroke, by as much as 26%

Orforglipron is not yet approved as a weight loss treatment in the UK, as it is still undergoing clinical trials